Deaths from breast cancer in Britain and the US have fallen by a quarter
since the late 1980s, report Oxford University epidemiologists in The
Lancet (vol 355, p 1822). The success is put down to earlier detection,
more prompt surgery and the use of hormonal drugs such as tamoxifen. But many
other countries are failing to use tamoxifen widely enough, according to
Christina Davies, one of the team.
More from New Scientist
Explore the latest news, articles and features
Technology
Test moderators use AI-generated writing to judge literacy standards
News
Mind
THC in cannabis may reduce nightmares in people with PTSD
News
Environment
Fishers detonate a bomb every hour on one Indonesian coral reef
News
Environment
How bad is the UK drought and how long will it continue?
News
Popular articles
Trending New Scientist articles